Home Stability of routine biochemical analytes in whole blood and plasma/serum: focus on potassium stability from lithium heparin
Article
Licensed
Unlicensed Requires Authentication

Stability of routine biochemical analytes in whole blood and plasma/serum: focus on potassium stability from lithium heparin

  • Anne Marie Dupuy , Jean Paul Cristol EMAIL logo , Bruno Vincent , Anne Sophie Bargnoux , Mickael Mendes , Pascal Philibert , Kadda Klouche and Stéphanie Badiou
Published/Copyright: September 9, 2017

Abstract

Background:

Blood specimens are transported from clinical departments to the biochemistry laboratory by hospital courier service, sometimes over long distances. The aim of this study was to assess the stability of common biochemical analytes in venous blood under our routine transport conditions and to evaluate analyte stability after prompt or delayed centrifugation.

Methods:

We investigated pre- and postanalytical contributions of 32 biochemical analytes in plasma and serum samples from 10 patients (healthy adults and patients from intensive care units). Differences in analyte concentrations between baseline (T0) and different time intervals (2, 4, 6, 8, 12 and 24 h) following storage after prompt and delayed centrifugation were reported. Evaluation was against the total change limit as described by Oddoze et al. (Oddoze C, Lombard E, Portugal H. Stability study of 81 analytes in human whole blood, in serum and in plasma. Clin Biochem 2012;45:464–9).

Results:

The majority of analytes were stable with delayed separation up to 12 h, except for potassium, C-peptide, osteocalcin, parathyroid hormone (PTH), bicarbonate and LDH. After prompt centrifugation and storage at 4°C, stability was greatly increased up to 48 h for most analytes. LDH and bicarbonate had the lowest stability after centrifugation; therefore, no reanalysis of these analytes in a centrifuged tube can be allowed.

Conclusions:

Knowledge of analyte stability is crucial to interpret biological analysis with confidence. However, centrifugation prior to transport is time consuming, and the transfer of plasma or serum from a primary tube to a secondary tube increases the risk of preanalytical errors. For analytes that are stable in whole blood for 24 h or more, it seems that there is no benefit to centrifuge before transport.

Acknowledgments

We gratefully acknowledge the biochemistry laboratory personnel for technical assistance.

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Oddoze C, Lombard E, Portugal H. Stability study of 81 analytes in human whole blood, in serum and in plasma. Clin Biochem 2012;45:464–9.10.1016/j.clinbiochem.2012.01.012Search in Google Scholar PubMed

2. Kumar V, Karon BS. Comparison of measured and calculated bicarbonate values. Clin Chem 2008;54:1586–7.10.1373/clinchem.2008.107441Search in Google Scholar PubMed

3. Boyanton BL Jr, Blick KE. Stability studies of twenty-four analytes in human plasma and serum. Clin Chem 2002;48:2242–7.10.1093/clinchem/48.12.2242Search in Google Scholar

4. Henriksen LO, Faber NR, Moller MF, Nexo E, Hansen AB. Stability of 35 biochemical and immunological routine tests after 10 hours storage and transport of human whole blood at 21°C. Scand J Clin Lab Invest 2014;74:603–10.10.3109/00365513.2014.928940Search in Google Scholar PubMed PubMed Central

5. Jensen EA, Stahl M, Brandslund I, Grinsted P. Stability of heparin blood samples during transport based on defined pre-analytical quality goals. Clin Chem Lab Med 2008;46:225–34.10.1515/CCLM.2008.053Search in Google Scholar PubMed

6. Leino A, Koivula MK. Stability of chemical and immunochemical analytes in uncentrifuged plasma samples. Ann Clin Biochem 2009;46:159–61.10.1258/acb.2008.008212Search in Google Scholar PubMed

7. Monneret D, Godmer A, Le Guen R, Bravetti C, Emeraud C, Marteau A, et al. Stability of routine biochemical analytes in whole blood and plasma from lithium heparin gel tubes during 6-hr storage. J Clin Lab Anal 2016;30:602–9.10.1002/jcla.21909Search in Google Scholar PubMed PubMed Central

8. Stahl M, Brandslund I. Controlled storage conditions prolong stability of biochemical components in whole blood. Clin Chem Lab Med 2005;43:210–5.10.1515/CCLM.2005.036Search in Google Scholar PubMed

9. Gowans EM, Hyltoft Petersen P, Blaabjerg O, Hørder M. Analytical goals for the acceptance of common reference intervals for laboratories throughout a geographical area. Scand J Clin Lab Invest 1988;48:757–64.10.3109/00365518809088757Search in Google Scholar PubMed

10. Fraser CG, Hyltoft Petersen P, Libeer JC, Ricos C. Proposals for setting generally applicable quality goals solely based on biology. Ann Clin Biochem 1997;34:8–12.10.1177/000456329703400103Search in Google Scholar PubMed

11. O’Keane MP, Cunningham SK. Evaluation of three different specimen types (serum, plasma lithium heparin and serum gel separator) for analysis of certain analytes: clinical significance of differences in results and efficiency in use. Clin Chem Lab Med 2006;44:662–8.10.1515/CCLM.2006.099Search in Google Scholar PubMed

12. Rodbard D. Statistical quality control and routine data processing for radioimmunoassays and immunoradiometric assays. Clin Chem 1974;20:1255–70.10.1093/clinchem/20.10.1255Search in Google Scholar

13. Dimeski G, Johnston J, Masci PP, Zhao KN, Brown N. Evaluation of the Greiner bio-one serum separator BCA fast clot tube. Clin Chem Lab Med 2017;55:1135–41.10.1515/cclm-2016-0806Search in Google Scholar PubMed

Received: 2017-4-3
Accepted: 2017-7-24
Published Online: 2017-9-9
Published in Print: 2018-2-23

©2018 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. Analytical quality: an unfinished journey
  4. Reviews
  5. Update in diagnosis and management of primary aldosteronism
  6. Diagnosis biomarkers in acute intestinal ischemic injury: so close, yet so far
  7. Opinion Papers
  8. Irregular analytical errors in diagnostic testing – a novel concept
  9. A Black Swan in clinical laboratory practice: the analytical error due to interferences in immunoassay methods
  10. General Clinical Chemistry and Laboratory Medicine
  11. Reaching consensus on communication of critical laboratory results using a collective intelligence method
  12. Stability of routine biochemical analytes in whole blood and plasma/serum: focus on potassium stability from lithium heparin
  13. GFR estimation based on standardized creatinine and cystatin C: a European multicenter analysis in older adults
  14. Binding of bromocresol green and bromocresol purple to albumin in hemodialysis patients
  15. Interlaboratory variability of urinary iodine measurements
  16. The venous thromboembolic risk and the clot wave analysis: a useful relationship?
  17. Hematology and Coagulation
  18. Autovalidation and automation of the postanalytical phase of routine hematology and coagulation analyses in a university hospital laboratory
  19. Reference Values and Biological Variations
  20. Indirect method for validating transference of reference intervals
  21. Differences in levels of albumin, ALT, AST, γ-GT and creatinine in frail, moderately healthy and healthy elderly individuals
  22. Cancer Diagnostics
  23. Serum exosomal hnRNPH1 mRNA as a novel marker for hepatocellular carcinoma
  24. Intragenic hypomethylation of DNMT3A in patients with myelodysplastic syndrome
  25. Cardiovascular Diseases
  26. Evaluation of analytical performance of a new high-sensitivity immunoassay for cardiac troponin I
  27. MEF2C loss-of-function mutation associated with familial dilated cardiomyopathy
  28. Letter to the Editor
  29. Hyperuricemia does not seem to be an independent risk factor for coronary heart disease
  30. Reply to: Hyperuricemia does not seem to be an independent risk factor for coronary heart disease
  31. Preanalytics of ammonia: stability, transport and temperature of centrifugation
  32. Influence of delayed separation of plasma from whole blood on Cu, I, Mn, Se, and Zn plasma concentrations
  33. Copeptin as a diagnostic and prognostic biomarker in patients admitted to Emergency Department with syncope, presyncope and vertiginous syndrome
  34. Development of an internally controlled quantitative PCR to measure total cell-associated HIV-1 DNA in blood
  35. Selective changes in cholesterol metabolite levels in plasma of breast cancer patients after tumor removal
  36. Athletes beware before throwing towels to audiences
Downloaded on 11.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2017-0292/html
Scroll to top button